Toggle navigation
Home
Search
Services
Blog
Contact
About
Assessing Safety of Cell Substrates and Vaccine Components
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Working Together for Resilient Youth
Human Immunodeficiency Virus(HIV)Prevention Projects for Cbo
Epidemiology & Natural History of Human T-Cell Lymphotro
G Protein Signaling and Skin Biology
Molecular Mechanism of Desensitization
Recently added grants:
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation
Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens
Feedback controlled, ultra-high-precision drug delivery
Elucidating CD47-SHP1 biology to understand autoinflammatory disorders
Development of Oncolytic Reovirus for Triple-Negative Breast Cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI40100-0-0-1
Application #
7579596
Study Section
Project Start
2004-09-24
Project End
2009-09-23
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2007
N01 AI
Assessing the Safety of Cell Substrates and Vaccine Components
Sampath, Rangarajan /
$1,063,489
NIH 2007
N01 AI
Assessing Safety of Cell Substrates and Vaccine Components
/
Comments
Be the first to comment on this grant